DC Healthcare Holdings Berhad (KLSE:DCHCARE)

KLSE:DCHCARE Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	86.13	55.79	67.7	51.96	25.48
Revenue Growth (YoY)	54.38%	-17.59%	30.28%	103.95%	76.34%
Cost of Revenue	42	34.55	29.29	22.76	11.55
Gross Profit	44.13	21.25	38.41	29.21	13.93
Selling, General & Admin	42.15	41.1	32.58	15.93	4.91
Other Operating Expenses	-1.64	-0.94	-0.43	-0.17	0.73
Operating Expenses	40.51	40.16	32.15	15.76	7.35
Operating Income	3.63	-18.91	6.25	13.45	6.58
Interest Expense	-1.96	-1.37	-1.21	-0.74	-0.56
Interest & Investment Income	-	-	-	-	0.03
Other Non Operating Income (Expenses)	-	-0.14	-0.3	-0.2	-
EBT Excluding Unusual Items	1.66	-20.42	4.74	12.51	6.05
Other Unusual Items	-	0	0.23	0.07	0.16
Pretax Income	1.66	-20.42	4.97	12.58	6.2
Income Tax Expense	1.45	-0.77	2.46	3.02	1.6
Net Income	0.21	-19.65	2.5	9.56	4.6
Net Income to Common	0.21	-19.65	2.5	9.56	4.6
Net Income Growth	-	-	-73.80%	107.71%	142.08%
Shares Outstanding (Basic)	996	996	889	797	996
Shares Outstanding (Diluted)	996	996	889	797	996
Shares Change (YoY)	-	12.10%	11.51%	-20.00%	-
EPS (Basic)	0.00	-0.02	0.00	0.01	0.00
EPS (Diluted)	0.00	-0.02	0.00	0.01	0.00
EPS Growth	-	-	-76.51%	159.62%	142.09%
Free Cash Flow	2.37	-3.61	-12.4	5.01	7.49
Free Cash Flow Per Share	0.00	-0.00	-0.01	0.01	0.01
Gross Margin	51.24%	38.08%	56.73%	56.21%	54.66%
Operating Margin	4.21%	-33.90%	9.24%	25.87%	25.82%
Profit Margin	0.24%	-35.22%	3.70%	18.39%	18.06%
Free Cash Flow Margin	2.75%	-6.48%	-18.32%	9.65%	29.39%
EBITDA	8.81	-13.83	8.29	14.41	6.85
EBITDA Margin	10.23%	-24.78%	12.24%	27.72%	26.88%
D&A For EBITDA	5.19	5.09	2.03	0.96	0.27
EBIT	3.63	-18.91	6.25	13.45	6.58
EBIT Margin	4.21%	-33.90%	9.24%	25.87%	25.82%
Effective Tax Rate	87.30%	-	49.58%	24.00%	25.81%
Advertising Expenses	-	-	-	-	2.08

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.